These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 2888156)

  • 1. Neuroleptic-induced oral dyskinesias: effects of progabide and lack of correlation with regional changes in glutamic acid decarboxylase and choline acetyltransferase activities.
    Mithani S; Atmadja S; Baimbridge KG; Fibiger HC
    Psychopharmacology (Berl); 1987; 93(1):94-100. PubMed ID: 2888156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Excitatory mechanisms in neuroleptic-induced vacuous chewing movements (VCMs): possible involvement of calcium and nitric oxide.
    Naidu PS; Kulkarni SK
    Behav Pharmacol; 2001 Jun; 12(3):209-16. PubMed ID: 11485057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoradiographic mapping of mu opioid receptor changes in rat brain after long-term haloperidol treatment: relationship to the development of vacuous chewing movements.
    Sasaki T; Kennedy JL; Nobrega JN
    Psychopharmacology (Berl); 1996 Nov; 128(1):97-104. PubMed ID: 8944412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-administration of progabide inhibits haloperidol-induced oral dyskinesias in rats.
    Kaneda H; Shirakawa O; Dale J; Goodman L; Bachus SE; Tamminga CA
    Eur J Pharmacol; 1992 Feb; 212(1):43-9. PubMed ID: 1555638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of nigral glutamic acid decarboxylase in rats with neuroleptic-induced oral dyskinesia.
    Gunne LM; Häggström JE
    Psychopharmacology (Berl); 1983; 81(3):191-4. PubMed ID: 6139837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parallels between behavioral and neurochemical variability in the rat vacuous chewing movement model of tardive dyskinesia.
    Bachus SE; Yang E; McCloskey SS; Minton JN
    Behav Brain Res; 2012 Jun; 231(2):323-36. PubMed ID: 22503783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological and neurochemical differences between acute and tardive vacuous chewing movements induced by haloperidol.
    Egan MF; Hurd Y; Ferguson J; Bachus SE; Hamid EH; Hyde TM
    Psychopharmacology (Berl); 1996 Oct; 127(4):337-45. PubMed ID: 8923569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroleptic-induced vacuous chewing movements as an animal model of tardive dyskinesia: a study in three rat strains.
    Tamminga CA; Dale JM; Goodman L; Kaneda H; Kaneda N
    Psychopharmacology (Berl); 1990; 102(4):474-8. PubMed ID: 1982902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mixture in the distribution of haloperidol-induced oral dyskinesias in the rat supports an animal model of tardive dyskinesia.
    Hashimoto T; Ross DE; Gao XM; Medoff DR; Tamminga CA
    Psychopharmacology (Berl); 1998 May; 137(2):107-12. PubMed ID: 9629996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of 5-HT1A and 5-HT2A/2C receptor modulation on neuroleptic-induced vacuous chewing movements.
    Naidu PS; Kulkarni SK
    Eur J Pharmacol; 2001 Sep; 428(1):81-6. PubMed ID: 11779040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of vacuous chewing movements with morphological changes in rats following 1-year treatment with haloperidol.
    Meshul CK; Andreassen OA; Allen C; Jørgensen HA
    Psychopharmacology (Berl); 1996 Jun; 125(3):238-47. PubMed ID: 8815959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoic acid and haloperidol-induced vacuous chewing movements: Implications for prophylactic antioxidant use in tardive dyskinesia.
    Lister J; Andreazza AC; Navaid B; Wilson VS; Teo C; Nesarajah Y; Wilson AA; Nobrega JN; Fletcher PJ; Remington G
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Jan; 72():23-29. PubMed ID: 27565433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progressive loss of glutamic acid decarboxylase, parvalbumin, and calbindin D28K immunoreactive neurons in the cerebral cortex and hippocampus of adult rat with experimental hydrocephalus.
    Tashiro Y; Chakrabortty S; Drake JM; Hattori T
    J Neurosurg; 1997 Feb; 86(2):263-71. PubMed ID: 9010428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of haloperidol-induced oral dyskinesias in rats by vigabatrin.
    Seiler N; Grauffel C; Elands J; van den Buuse M; Knödgen B; Sarhan S; Moran P; Gobaille S
    Pharmacol Biochem Behav; 1995 Feb; 50(2):181-9. PubMed ID: 7740056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electron spin resonance spectroscopy reveals alpha-phenyl-N-tert-butylnitrone spin-traps free radicals in rat striatum and prevents haloperidol-induced vacuous chewing movements in the rat model of human tardive dyskinesia.
    Rogoza RM; Fairfax DF; Henry P; N-Marandi S; Khan RF; Gupta SK; Mishra RK
    Synapse; 2004 Dec; 54(3):156-63. PubMed ID: 15452862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental tardive dyskinesia.
    Gunne LM; Häggström JE
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):48-50. PubMed ID: 2858481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of haloperidol on cholinergic striatal interneurons: relationship to oral dyskinesias.
    Kelley JJ; Roberts RC
    J Neural Transm (Vienna); 2004 Aug; 111(8):1075-91. PubMed ID: 15254795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of orofacial movements to behavioural repertoire as assessed topographically over the course of 6-month haloperidol treatment followed by 4-month withdrawal.
    De Souza IE; Dawson NM; Clifford JJ; Waddington JL; Meredith GE
    Psychopharmacology (Berl); 2003 Aug; 169(1):28-34. PubMed ID: 12830366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral dyskinesias and morphological changes in rat striatum during long-term haloperidol administration.
    Andreassen OA; Meshul CK; Moore C; Jørgensen HA
    Psychopharmacology (Berl); 2001 Aug; 157(1):11-9. PubMed ID: 11512038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure to down regulate NMDA receptors in the striatum and nucleus accumbens associated with neuroleptic-induced dyskinesia.
    Hamid EH; Hyde TM; Baca SM; Egan MF
    Brain Res; 1998 Jun; 796(1-2):291-5. PubMed ID: 9689480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.